期刊文献+

糖尿病患者人危险病毒因素的变化及其临床意义 被引量:5

The Change of Dangerous Virus Factors of Diabetic Patients and Its Clinical Significance
原文传递
导出
摘要 观察糖尿病患者人巨细胞病毒(HCMV)、柯萨奇B组病毒(CVB)和胰岛细胞抗体(ICA)、谷氨酸脱羧酶抗体(GADAb)及空腹血糖水平(FPG)的变化,分析其临床意义,选取我院2012年10月到2014年10月期间,收治的糖尿病患者共130例。根据糖尿病患者的病情将患者分为1型糖尿病患者(T1DM)和2型糖尿病患者(T2DM),每组各65例,1型糖尿病患者(T1DM)为A组,2型糖尿病患者(T2DM)为B组,另外再选取65例健康人作对照C组,对各组人员的胰岛细胞抗体(ICA)、谷氨酸脱羧酶抗体(GADAb)及空腹血糖水平(FPG)、人巨细胞病毒Ig M抗体(HCMV-Ig M)、人巨细胞病毒Ig G抗体(HCMV-Ig G)、柯萨奇B组病毒Ig M抗体(CVB-Ig M)水平进行检测,并探究其临床意义。比较ICA、GADAb、抗HCMV-Ig M、抗HCMV-Ig G、抗CVB-Ig M,A组的阳性率分别为32.3%、72.3%、43.1%、58.5%、26.2%,B组的阳性率分别为3.2%、41.5%、7.7%、24.6%、3.1%,C组人员的阳性率为3.1%、21.5%、3.1%、3.1%、0%,A、B两组分别与C组比较,B组的抗HCMV-Ig G和ICA抗体的检测阳性率与C组有明显的差异(p<0.05)。FPG水平比较,A、B、C三组具有明显的差异(p<0.05)。检测人巨细胞病毒(HCMV)、柯萨奇B组病毒(CVB)和胰岛细胞抗体(ICA)、谷氨酸脱羧酶抗体(GADAb)及空腹血糖水平(FPG)水平,对糖尿病患者的临床诊断具有重要的意义。 To observe the cytomegalovirus(HCMV), Coxsackie virus B(CVB) and islet cell antibodies(ICA) of diabetes patients, the change of glutamic acid decarboxylase antibody(GADAb) and fasting blood glucose(FPG)as well as analyze the clinical significance, our hospital has received and cured a total of 130 cases of diabetic patients from October 2012 to October 2014. According to the condition of diabetes patients, the patients were divided into type 1 diabetes mellitus(T1DM) and type 2 diabetes(T2DM). Each group contained 65 cases. Patients with type 1 diabetes mellitus(T1DM) was Group A, while patients with type 2 diabetes mellitus(T2DM) was group B, and then we selected 65 cases of healthy persons as control group C. The islet cell antibodies(ICA),glutamic acid decarboxylase antibody(GADAb) and fasting blood glucose(FPG), human cytomegalovirus Ig M antibody(HCMV-Ig M), human cytomegalovirus Ig G antibody(HCMV-Ig G) and Coxsackie B virus Ig M antibody(CVB-Ig M) levels of each team were detected, and explored their clinical significance. Compared with ICA,GADAb, anti HCMV-Ig M, HCMV-Ig G, the positive rate of Group A were 32.3%、72.3%、43.1%、58.5%、26.2%,respectively, while the positive rate of Group B were 3.2%、41.5%、7.7%、24.6%、3.1%, respectively, as well as the positive rate of Group C were 3.1%, 21.5%, 3.1%, 3.1%, 0%, respectively. Group A and Group B were compared with group C. The positive rate of HCMV-Ig G and ICA antibody detection of group B had significant difference compared with group C(p〈0.05). By FPG level comparison, A, B, C three groups had significant differences(p〈0.05). Detection of human cytomegalovirus(HCMV), Coxsackie B group of viruses(CVB) and islet cell antibodies(ICA), glutamic acid decarboxylase antibody(GADAb) and fasting plasma glucose levels(FPG) levels in patients with diabetes played an important role in the clinical diagnosis of diabetes patients.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2016年第4期775-778,共4页 Genomics and Applied Biology
关键词 1型、2型糖尿病 人巨细胞病毒 柯萨奇B组病毒 胰岛细胞抗体 谷氨酸脱羧酶抗体 Type 1,Type 2 diabetes mellitus Human cytomegalovirus Coxsackie B virus Islet cell antibody Glutamic acid decarboxylase antibody
  • 相关文献

参考文献9

  • 1Haller-Kikkatalo K., Pruul K., Kisand K., Nemvalts V., Reimand K., and Uibo R., 2015, GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults, Euro- pean Joumal of Clinical Investigation, 45(3): 255-262.
  • 2Han J.F., Yu N., Pan Y.X., He S.J., Xu L.J., Cao R.Y., Li Y.X., Zhu S.Y., Zhang Y., and Qin E.D., 2014, Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice, Virus Research, 179: 212-219.
  • 3Li H., Li W., Liu X., and Cao Y., 2013, gadA gene locus in Lacto- bacillus brevis NCL912 and its expression during fed-batch fermentation, FEMS Microbiology Letters, 349(2): 108-116.
  • 4Li M., Wang X., Yu Y., Yu Y., Xie Y., Zou Y., Ge J., Peng T., and Chen R., 2014, Coxsackievirus B3 induced calpain ac- tivation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells, Virus Research, 179:177-186.
  • 5Lupton J., Vemamonti J., McCabe C., Noble J., Yin H.Z., Eyre R.C., and Kiessling A.A., 2014, Cytomegalovirus and hu- man immunodeficieney virus in semen of homosexual men, Fertility and Sterility, 101(2): 350-358.
  • 6邱春婷,王怡,周莉,高敏,卢诚震,郭洁.血清谷氨酸脱羧酶抗体在诊断肝源性糖尿病中的价值[J].广东医学,2013,34(13):2066-2068. 被引量:4
  • 7White A.L., Hedlund G.L., and Bale J.F., 2014, Congenital cy- tomegalovirus infection and brain clefting, Pediatric Neurol- ogy, 50(3): 218-223.
  • 8徐晓娜,陈尔飞,杨进.2型糖尿病与营养基因组学[J].基因组学与应用生物学,2015,34(2):417-420. 被引量:6
  • 9邹婧,刘煜.锌转运蛋白8表位与1型糖尿病的研究进展[J].中华糖尿病杂志,2015,7(4):263-265. 被引量:3

二级参考文献53

  • 1张玲,石亚玲,洪文昕,贾卫东,姚斌,石裕明.血清谷氨酸脱羧酶抗体、胰岛细胞抗体在肝源性糖尿病诊断中的价值[J].中华传染病杂志,2004,22(3):193-195. 被引量:3
  • 2WHO. Report of the expert committee on diagnosis and classifica-tion of diabetes mellitus[ J]. Diabetes Care, 1997, 20(7) : 1183 -1197.
  • 3BAEKKESKOV S, NIELSEN J H, MAMER B, et al. Antiboies innewly diagnosed diabetes children [ J ]. Nature, 1982, 298(5870):167 -169.
  • 4BROPHY S,YDERSTRAEDE K, MAURICIO D, et al. Time toinsulin initiation cannot be used in defining latent autoimmune dia-betes in adults[ J]. Diabetes Care, 2008 , 31 (3) : 439 -441.
  • 5Shivaprasad C,Mittal R,Dharmalingam M, et al. Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India[J].Indian J Endocrinol Metab, 2014, 18(3): 345-349.
  • 6Chujo D, Foucat E, Nguyen TS, et al. ZnT8-specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adults[J]. PLoS ONE, 2013, 8(2): e55595.
  • 7Skarstrand H, Lemmark A, Vaziri-Sani F.Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes [J].Scand J Immunol,2013,77(1):21-29.
  • 8Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes[J], Proc Natl Acad Sci USA, 2007, 104(43): 17040-17045.
  • 9Kawasaki E, Nakamura K, Kuriya G, et al. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients[J]. Clin Immunol, 2011,138(2): 146-153.
  • 10Kawasaki E, Nakamura K, Kuriya G, et al. Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes[J]. Diabetes Metab Res Rev, 2011, 27(8): 895-898.

共引文献10

同被引文献56

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部